HOWL
Werewolf Therapeutics Inc

857
Loading...
Loading...
News
all
press releases
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Zacks·8d ago
News Placeholder
More News
News Placeholder
XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates
XOMA Royalty (XOMA) delivered earnings and revenue surprises of +500.00% and +39.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
Beyond Air (XAIR) delivered earnings and revenue surprises of -2.00% and -1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
CorMedix (CRMD) Surpasses Q2 Earnings and Revenue Estimates
CorMedix (CRMD) delivered earnings and revenue surprises of +40.00% and +7.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
Zacks·4mo ago
News Placeholder
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates
chainwire·4mo ago
News Placeholder
Where Werewolf Therapeutics Stands With Analysts
Latest Ratings for HOWL DateFirmActionFromTo Nov 2021SVB LeerinkMaintainsOutperform Sep 2021B of A SecuritiesInitiates Coverage OnBuy May 2021Evercore ISI GroupInitiates Coverage OnOutperform...
Benzinga·1y ago
News Placeholder
Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know
Latest Ratings for HOWL DateFirmActionFromTo Nov 2021SVB LeerinkMaintainsOutperform Sep 2021B of A SecuritiesInitiates Coverage OnBuy May 2021Evercore ISI GroupInitiates Coverage OnOutperform...
Benzinga·1y ago
News Placeholder
The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts
Latest Ratings for HOWL DateFirmActionFromTo Nov 2021SVB LeerinkMaintainsOutperform Sep 2021B of A SecuritiesInitiates Coverage OnBuy May 2021Evercore ISI GroupInitiates Coverage OnOutperform...
Benzinga·1y ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Research Coverage Started at JMP Securities
JMP Securities started coverage on shares of Werewolf Therapeutics (NASDAQ:HOWL - Free Report) in a research note published on Wednesday, Marketbeat.com reports. The firm issued a mkt outperform...
Zolmax·1y ago

Latest HOWL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.